drugset / Trial / NCT06570850

Colistin Monotherapy vs Colsitin-fosfomycine in CRAB Infection

NCT06570850

Phase 4 Recruiting 188 enrolled Chiang Mai University
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to evaluate the efficacy of colistin compared with colistin plus fosfomycin against carbapenem-resistant Acinetobacter baumanii infection in Thailand. The main questions it aims to answer the following main questions: 1. Which group has better clinical response at end of treatment 2. Which group has better clinical response at 72 hours and micrological cure at 72 hours and at end of treatment

Timeline

Start
2023-04-01
Primary completion
2025-03
Completion
2025-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Colistimethate Unknown 5 mg/kg Intravenous
Comparator Colistimethate Unknown 80 mg Intravenous
Comparator Fosfomycin Small molecule Intravenous